Literature DB >> 11857089

Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma.

Xiao-lu Yin1, Jesse Chung-sean Pang, Ho-keung Ng.   

Abstract

To identify critical tumor suppressor loci that are associated with the development of medulloblastoma, we performed a comprehensive genome-wide allelotype analysis in a series of 12 medulloblastomas. Non-random allelic imbalances were identified on chromosomes 7q (58.3%), 8p (66.7%), 16q (58.3%), 17p (58.3%) and 17q (66.7%). Comparative genomic hybridization analysis confirmed that allelic imbalances on 8p, 16q and 17p were due to loss of genetic materials. Finer deletion mapping in an expanded series of 23 medulloblastomas localized the common deletion region on 8p to an interval of 18.14 cM on 8p22-23.2. We then searched within the region of loss on 8p for loci that might contain homozygous deletion using comparative duplex PCR. An overlapping homozygous deletion region was identified in a 1.8 cM interval on 8p22-23.1, between markers D8S520 and D8S1130, in two medulloblastomas. This region of homozygous deletion also encompasses the 1.4 cM minimal deletion region detected on 8p in ductal carcinoma in situ of breast. In conclusion, we reported for the first time a detailed deletion mapping on 8p in medulloblastoma and have identified a region of homozygous deletion on 8p22-23.1 that is likely to contain a critical tumor suppressor gene involved in the development of medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857089     DOI: 10.1038/sj.onc.1205204

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

Review 1.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

2.  High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.

Authors:  Y-F Song; R Xu; X-H Zhang; B-B Chen; Q Chen; Y-M Chen; Y Xie
Journal:  J Clin Pathol       Date:  2006-02-17       Impact factor: 3.411

3.  Analysis of DLC-1 expression in human breast cancer.

Authors:  Marlies Plaumann; Susanne Seitz; Renate Frege; Lope Estevez-Schwarz; Siegfried Scherneck
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

4.  High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.

Authors:  Martin Gerard McCabe; Koichi Ichimura; Lu Liu; Karen Plant; L Magnus Bäcklund; Danita M Pearson; Vincent Peter Collins
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

5.  Genetic differences between Asian and Caucasian chronic lymphocytic leukemia.

Authors:  Norihiko Kawamata; Chimene Moreilhon; Takayuki Saitoh; Masamitsu Karasawa; Brian K Bernstein; Aiko Sato-Otsubo; Seishi Ogawa; Sophie Raynaud; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2013-05-27       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.